Skip to content

Preparation, characterization, and comparison of the release of antibacterial peptide CM11 from PLGA nanoparticles and microparticles

2026 · Iranian Journal of Basic Medical Sciences · Vol 29, pp. 1648 - 1658 · 0 citations · 26 references
Medicine

TL;DR

NPCM11 and MPCM11 were promising formulations of CM11 for treating P. aeruginosa infections and MTT assay revealed that NPCM11 and MPCM11 significantly reduced CM11 cytotoxicity.

Abstract

Objective(s): Pseudomonas aeruginosa (P. aeruginosa) is a Gram-negative bacterium capable of causing acute and chronic infections. Treating these infections is increasingly challenging as this bacterium develops antibiotic resistance. Antimicrobial peptides (AMPs) have emerged as promising therapeutic candidates due to their broad-spectrum activity. Cecropin-Melittin-11 (CM11), a cationic AMP, has shown antimicrobial activity against various pathogens. However, the progression of AMPs from preclinical research to clinical application is hindered by enzymatic degradation, short systemic half-life, and cytotoxicity. To overcome these challenges, poly(lactic-co-glycolic acid)(PLGA) particles for peptide delivery have gained attention. Materials and Methods: CM11-loaded PLGA nanoparticles (NPCM11) and microparticles (MPCM11) were prepared using a double-emulsion solvent evaporation (W1/O/W2) method and characterized for particle size, morphology, encapsulation efficiency, and in vitro release. Their antibacterial activity against planktonic and biofilm-forming P. aeruginosa was evaluated using broth microdilution assay. Their cytocompatibility was evaluated using 3-(4,5-Dimethylthiazol-2-yl)-2,5-Diphenyltetrazolium Bromide (MTT) assay. Results: Optimum formulations of NPCM11 and MPCM11 were synthesized, exhibiting spherical morphology with average sizes of 281 nm and 7.63 µm, respectively. The encapsulation efficiency (EE%) of NPCM11 and MPCM11 was 63.5% and 60.3%, respectively, while the in vitro CM11 release was 82% and 58%. According to broth microdilution and biofilm inhibition assays, NPCM11 outperformed free CM11 and MPCM11 against planktonic bacteria, whereas both NPCM11 and MPCM11 were superior to free CM11 in biofilm inhibition. MTT assay revealed that NPCM11 and MPCM11 significantly reduced CM11 cytotoxicity. Conclusion: Overall, NPCM11 and MPCM11 were promising formulations of CM11 for treating P. aeruginosa infections.

View source

Similar papers

Open access Sep 2026

PLGA nanoparticles for the delivery of antimicrobial peptides in a polymicrobial sepsis model.

Enhanced therapeutic potential for scorpion-derived AMP analogs-loaded PLGA nanoparticles is demonstrated, providing a dual antimicrobial and anti-inflammatory strategy for severe infections such as sepsis, and support further development of AMP-based nanomedicines.

Bruno Amorim-Carmo, Emanuell Santos-Silva, Alessandra Daniele-Silva et al. · 0 citations
Jan 2026

Development of Novel Antimicrobial Peptides and Their Engineering into Nanoparticles to Improve Performance.

This study identified potent AMPs with promising therapeutic potential by constructing and screening a synthetic random peptide library using a bacterial surface display system, and identified WP-4 and WP-6, which showed high antimicrobial activity, good biocompatibility, rapid bactericidal effects, and low propensity...

Shuai-Yang Wang, Shuang Wang, Xiu-Jian Liu et al. · 0 citations
Open access Sep 2026

Optimized Chitosan Nanoparticles for Enhanced Ciprofloxacin Delivery and Activity Against Resistant Bacteria

Background/Objectives: Ciprofloxacin (CIP) is a fluoroquinolone extensively used in hospital settings for the treatment of bacterial infections; however, this antibiotic requires multiple doses because it has poor absorption, rapid elimination, and is ineffective against resistant bacterial strains. Enhanced delivery e...

Lina Alharbi, Ghaida Abalkhail, Fatimah Alabrah et al. · 0 citations
Open access Nov 2026

Synthesis, Characterization, and Antibacterial Efficacy of Cu-ZIF-8: In Vitro Study of Multidrug-Resistant Gram-Positive and Gram-Negative Bacteria

Recently, Staphylococcus aureus and Pseudomonas aeruginosa have become multidrug-resistant (MDR) and produce many virulence factors, posing a health risk. Therefore, addressing knowledge gaps and finding solutions to the challenge caused by bacteria's increased resistance to multiple antibiotics is an urgent need. To a...

Nibras Saleh Ghafel Al Tameemi, I. Abdul-Husin, Raid Razzaq Ojaimi et al. · 0 citations
Open access Oct 2026

Calixarene-based nanocarrier for ciprofloxacin and curcumin: evaluation of antibacterial, antibiofilm, antioxidant and anti-inflammatory activities.

The multifunctional nature of the nanoassemblies highlights their potential for combining antimicrobial, radical-scavenging and anti-inflammatory properties, offering a promising approach to addressing the complex challenges associated with bacterial infections, including those involving biofilms.

Loredana Ferreri, Lucia Cambria, G. Ginestra et al. · 0 citations
Open access Oct 2026

Formulation and Evaluation of Thymoquinone- and Nicotinamide-Loaded Nanostructured Lipid Carriers Combined with Azithromycin Against Staphylococcus aureus and Pseudomonas aeruginosa

Multidrug-resistant (MDR) bacteria pose a significant global health threat, limiting therapeutic options and increasing morbidity, mortality, and healthcare costs. To address this challenge, combinations of natural compounds with existing antibiotics encapsulated in nanostructured lipid carriers (NLCs), are increasingl...

A. A. Abdulkareem, Zainab Lafi, Hala Al-Daghistani · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.